--- title: RWD, a game changer - Check out Cegedim Health Data’s blog description: The Cegedim Health Data blog decodes what’s on the horizon for Real-World Data and Real-World Evidence. Find out more! --- [Skip to content](https://blog.cegedim-health-data.com#main-content) [![logo_w_shape](https://blog.cegedim-health-data.com/hubfs/assets/images/logo_w_shape.svg "logo_w_shape")](https://www.cegedim-health-data.com/) - [Home](https://www.cegedim-health-data.com/) - [About us](https://www.cegedim-health-data.com/cegedim-health-data/about-us/) - [Solutions](https://www.cegedim-health-data.com/solutions/) - [THIN](https://www.cegedim-health-data.com/cegedim-health-data/thin-the-health-improvement-network/) - [Resources](https://www.cegedim-health-data.com/resources/) - [Contact](https://www.cegedim-health-data.com/contact-us/) Open the Search # RWD, a game changer... Decoding what’s on the horizon for RWD and RWE - [Toutes les Catégories](https://blog.cegedim-health-data.com) - [Rare Diseases](https://blog.cegedim-health-data.com/tag/rare-diseases) - [Read Rare diseases: How real-world data can help deliver new therapies](https://blog.cegedim-health-data.com/rare-diseases-how-real-world-data-can-help-deliver-new-therapies) ![Rare diseases: How real-world data can help deliver new therapies](https://blog.cegedim-health-data.com/hs-fs/hubfs/Pillar%20page%20-1.png?width=570&height=340&name=Pillar%20page%20-1.png) - [Rare Diseases](https://blog.cegedim-health-data.com/tag/rare-diseases) ## Rare diseases: How real-world data can help deliver new therapies - 2023/02/17 - 7min read In Europe, 30 million people live with rare diseases, for many of which currently there is no available treatment. Although pharmaceutical companies are continuously working to develop new therapies, the traditional way of conducting randomised... Read the Article - [Read How is RWD governance evolving to improve decision-making in Europe?](https://blog.cegedim-health-data.com/how-is-rwd-governance-evolving-to-improve-decision-making-in-europe) ![How is RWD governance evolving to improve decision-making in Europe?](https://blog.cegedim-health-data.com/hs-fs/hubfs/Article%206_%20How%20is%20RWD%20governance%20evolving%20to%20improve%20regulatory%20decision-making%20in%20Europe.png?width=570&height=340&name=Article%206_%20How%20is%20RWD%20governance%20evolving%20to%20improve%20regulatory%20decision-making%20in%20Europe.png) - [Rare Diseases](https://blog.cegedim-health-data.com/tag/rare-diseases) ## How is RWD governance evolving to improve decision-making in Europe? - 2023/02/14 - 3min read Since March 2020 the EMA has been actively following a strategy named “Regulatory Science to 2025” in order to advance its engagement with regulatory science over the next five to ten years. The EMA are aware that massive amounts of data that could... Read the Article - [Read Why RWD in rare diseases needs a common data model](https://blog.cegedim-health-data.com/why-rwd-in-rare-diseases-needs-a-common-data-model) ![Why RWD in rare diseases needs a common data model](https://blog.cegedim-health-data.com/hs-fs/hubfs/Article%205_%20Why%20RWD%20in%20rare%20diseases%20needs%20a%20common%20data%20model.png?width=570&height=340&name=Article%205_%20Why%20RWD%20in%20rare%20diseases%20needs%20a%20common%20data%20model.png) - [Rare Diseases](https://blog.cegedim-health-data.com/tag/rare-diseases) ## Why RWD in rare diseases needs a common data model - 2023/02/14 - 2min read When it comes to rare diseases, Real-World Data (RWD) precision can be lost when aggregating samples across countries, and there is a strong case to create a common data model in Europe to form a single population where multiple autonomous sources... Read the Article - [Read 5 ways to make optimal use of RWD in rare diseases](https://blog.cegedim-health-data.com/5-ways-to-make-optimal-use-of-rwd-in-rare-diseases) ![5 ways to make optimal use of RWD in rare diseases](https://blog.cegedim-health-data.com/hs-fs/hubfs/Article%204_%205%20ways%20to%20make%20optimal%20use%20of%20RWD%20in%20rare%20diseases.png?width=570&height=340&name=Article%204_%205%20ways%20to%20make%20optimal%20use%20of%20RWD%20in%20rare%20diseases.png) - [Rare Diseases](https://blog.cegedim-health-data.com/tag/rare-diseases) ## 5 ways to make optimal use of RWD in rare diseases - 2023/02/14 - 3min read Rare disease come with some specific considerations that affect the optimal use of Real-World Data (RWD), including factors that arise due to limited patients and limited data. Read the Article - [Read 3 RWD challenges for pharma aiming to modernise rare disease research](https://blog.cegedim-health-data.com/3-rwd-challenges-for-pharma-aiming-to-modernise-rare-disease-research) ![3 RWD challenges for pharma aiming to modernise rare disease research](https://blog.cegedim-health-data.com/hs-fs/hubfs/Article%203_%203%20top%20RWD%20challenges%20for%20pharma%20companies%20aiming%20to%20modernise%20rare%20disease%20research.png?width=570&height=340&name=Article%203_%203%20top%20RWD%20challenges%20for%20pharma%20companies%20aiming%20to%20modernise%20rare%20disease%20research.png) - [Rare Diseases](https://blog.cegedim-health-data.com/tag/rare-diseases) ## 3 RWD challenges for pharma aiming to modernise rare disease research - 2023/02/14 - 3min read There are multiple challenges when dealing with Real-World Data (RWD) in rare diseases, from how to organize teams and plan operational capabilities, to small sample sizes introducing statistical limitations and data protection restrictions, to RWD... Read the Article - [Read RWD and RWE: 6 opportunities in rare diseases](https://blog.cegedim-health-data.com/rwd-and-rwe-6-opportunities-in-rare-diseases) ![RWD and RWE: 6 opportunities in rare diseases](https://blog.cegedim-health-data.com/hs-fs/hubfs/Article%202_%20RWD%20and%20RWE_%206%20opportunities%20in%20rare%20disease.png?width=570&height=340&name=Article%202_%20RWD%20and%20RWE_%206%20opportunities%20in%20rare%20disease.png) - [Rare Diseases](https://blog.cegedim-health-data.com/tag/rare-diseases) ## RWD and RWE: 6 opportunities in rare diseases - 2023/02/14 - 4min read Real-World Data (RWD) and Real-World Evidence (RWE) present several opportunities in application to rare diseases, including supplementing clinical trials data for drug approval applications, better understanding the disease itself, expanding the... Read the Article - [Read How can RWD and RWE supplement clinical trial data in rare diseases?](https://blog.cegedim-health-data.com/how-can-rwd-and-rwe-supplement-clinical-trial-data-in-rare-diseases) ![How can RWD and RWE supplement clinical trial data in rare diseases?](https://blog.cegedim-health-data.com/hs-fs/hubfs/Article%201_%20How%20can%20RWD%20and%20RWE%20supplement%20clinical%20trial%20data%20in%20rare%20diseases.png?width=570&height=340&name=Article%201_%20How%20can%20RWD%20and%20RWE%20supplement%20clinical%20trial%20data%20in%20rare%20diseases.png) - [Rare Diseases](https://blog.cegedim-health-data.com/tag/rare-diseases) ## How can RWD and RWE supplement clinical trial data in rare diseases? - 2023/02/14 - 3min read The healthcare industry stores over 2,300 exabytes of healthcare data, according to the World Economic Forum, with the vast majority going unused, siloed in different formats, structures, and locations. Read the Article ## Subscribe to our Newsletter In this newsletter, Gilles Paubert, the Global Head of Cegedim Health Data, shares some of his favorite recent datascience and RWD articles… *By subscribing to this newsletter, you consent to GERS (Cegedim Health Data), the data controller, processing your data for such purpose. In accordance with the GDPR and French law n° 78-17 of 6 January 1978 (Informatique et Libertés), as amended, you have the right to access, rectify, erase, restrict and object to the processing of your personal data and the right to data portability. You may exercise these rights by sending an email to the following address: [cnil.gers@gers-sas.fr](mailto:cnil.gers@gers-sas.fr); or by writing to GERS, DPO, 137 rue d'Aguesseau - 92100 Boulogne-Billancourt, France. If you feel, after contacting us, that your "Data Protection" rights are not respected, you may submit a complaint to the CNIL.* ## Have any questions about our activities? [Contact Us](https://www.cegedim-health-data.com/contact-us/) - ### Solutions - [Real World Evidence Services](https://www.cegedim-health-data.com/solutions/real-world-evidence-services/real-world-evidence-services/) - [Patient Intelligence](https://www.cegedim-health-data.com/solutions/real-world-data-evidences/patient-intelligence/) - [Market Intelligence](https://www.cegedim-health-data.com/solutions/real-world-data-evidences/market-intelligence/) - [Real World Data](https://www.cegedim-health-data.com/solutions/real-world-data-evidences/patient-cohort/) - ### Resources - [News](https://www.cegedim-health-data.com/news/) - [Documentation](https://www.cegedim-health-data.com/documentation/) - [Blog](https://blog.cegedim-health-data.com/) - ### Cegedim Health Data - [About Us](https://www.cegedim-health-data.com/cegedim-health-data/about-us/) - [THIN: The Health Improvement N...](https://www.cegedim-health-data.com/cegedim-health-data/thin-the-health-improvement-network/) - [Publications](https://www.the-health-improvement-network.com/resources-hub) - ### Contact - [Contact Us](https://www.cegedim-health-data.com/contact-us/) - [Legal information](https://www.cegedim-health-data.com/legal-information/) Follow Cegedim Health Data on social networks - [Suivez-nous sur LinkedIn](https://www.linkedin.com/company/cegedim-health-data/) Copyright © 2026 Cegedim Health Data - All rights reserved - [Terms of use](https://www.cegedim-health-data.com/privacy-policy/) - [A Cegedim Group company](https://www.cegedim.com/Pages/default.aspx)